San Francisco, CA, United States of America

James A Lee

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Magnifica Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James A Lee. Retrieved from https://idiyas.com/inventor/james-a-lee-3s31mmhv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by James A. Lee

Introduction

James A. Lee is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of oral particle compositions, particularly in the development of extended-release tablet formulations. His innovative approach has led to the creation of a unique oral particle composition that enhances the effectiveness of medications.

Latest Patents

James A. Lee holds a patent for "Oral particle compositions containing a core and an acid-soluble coat." This invention relates to an oral particle composition that includes a core and a coat, where the coat is designed to be acid-soluble. This advancement is crucial for improving the delivery and efficacy of pharmaceutical formulations. He has 1 patent to his name.

Career Highlights

James A. Lee is currently associated with Magnifica Inc., where he continues to innovate and develop new solutions in the pharmaceutical industry. His work focuses on enhancing drug delivery systems, which is vital for patient care and treatment outcomes.

Collaborations

James collaborates with David N. Wong, leveraging their combined expertise to push the boundaries of pharmaceutical innovations. Their partnership has been instrumental in advancing research and development within their field.

Conclusion

James A. Lee's contributions to the field of oral particle compositions demonstrate his commitment to innovation in pharmaceuticals. His work not only enhances drug delivery but also improves patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…